Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Biocardia Inc (BCDA)

Biocardia Inc (BCDA)
2.13 -0.11 (-5.07%) 01/10/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
News & Headlines for Fri, Jan 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
BioCardia Announces Commercial Availability of Morph® DNA™ Steerable Introducer Product Family

BCDA : 2.13 (-5.07%)
BioCardia, Inc. Completes Consultation with Japan's PMDA on BCDA-01 for Ischemic Heart Failure Treatment

BioCardia announces consultation success with PMDA for BCDA-01 registration, targeting ischemic heart failure treatment. Data expected Q1 2025.Quiver AI SummaryBioCardia, Inc., a leader in cell-derived...

BCDA : 2.13 (-5.07%)
BioCardia Announces Positive Consultation with Japan PMDA on CardiAMP Cell Therapy for Ischemic Heart Failure

BCDA : 2.13 (-5.07%)
BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results

BCDA : 2.13 (-5.07%)
BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024

BCDA : 2.13 (-5.07%)
BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure

BCDA : 2.13 (-5.07%)
BioCardia Announces FDA Approval of IND Application for Allogeneic NK1R+ Human Mesenchymal Stem Cells for Ischemic Heart Failure

BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced Food and Drug Administration (FDA) approval...

BCDA : 2.13 (-5.07%)
BioCardia Reports Second Quarter 2022 Business Highlights And Financial Results

SUNNYVALE, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the...

BCDA : 2.13 (-5.07%)
BioCardia to Host Q2 2022 Financial Results and Corporate Update Conference Call on August 10, 2022

SUNNYVALE, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the...

BCDA : 2.13 (-5.07%)
BioCardia Announces First Canadian Clinical Site for CardiAMP Cell Therapy Heart Failure Trial

SUNNYVALE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the...

BCDA : 2.13 (-5.07%)

Barchart Exclusives

Why Quantum Computing Inc (QUBT) Could Be the Deep Value Outlier
Thanks to the quantum fallout, speculators are eyeballing extreme discounts but only QUBT stock gives traders somewhat favorable odds. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Trading Volume: The most powerful technical indicator in the world